- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Menu
Therapeutic Tebentafusp bispecific fusion protein from original Kimmtrak® commercial drug.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
CD3 , TCR targeting domain |
Bispecific fusion protein |
Kimmtrak® |
0,2 mg/mL |
– |
0.01 mg |
tba |
tba |
4.602,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany
